Literature DB >> 32900009

COVID-19 and ESKD, A Rapid Review.

Ankur D Shah1, Nathan Calabro-Kailukaitis2.   

Abstract

In 2020, the COVID-19 pandemic has ravaged the world. Individuals with end-stage kidney disease (ESKD) are at higher risk due to impaired immunity, comorbid conditions, and dependence on travel to medical care settings. We review the salient features of COVID-19 in this population, including the risk of infection, disease course, changes in dialysis unit management, use of investigatory medications, access considerations, home dialysis, and capacity planning.

Entities:  

Keywords:  COVID-19; coronavirus; dialysis; end-stage kidney disease

Mesh：

Year:  2020        PMID： 32900009

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN： 0363-7913


  2 in total

1.  Presentation and outcomes of chronic kidney disease patients with COVID-19.

Authors:  Carolina Gonçalves Branco; Inês Duarte; Joana Gameiro; Cláudia Costa; Filipe Marques; João Oliveira; João Bernardo; José Nuno Fonseca; Carolina Carreiro; Sandra Braz; José António Lopes
Journal:  J Bras Nefrol       Date:  2022 Jul-Sep

2.  SARS-CoV-2 Infection in Patients on Dialysis: Incidence and Outcomes in the Lazio Region, Italy.

Authors:  Claudia Marino; Laura Angelici; Valentina Pistolesi; Santo Morabito; Anteo Di Napoli; Enrico Calandrini; Silvia Cascini; Anna Maria Bargagli; Nicola Petrosillo; Nera Agabiti; Marina Davoli
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.